Coagulation Parameters During Pregnancy in Amniotic Fluid

Rambam Health Care Campus170 enrolled

Overview

Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.

Study Type

OBSERVATIONAL

Enrollment

170

Conditions

Pregnancy

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women undergoing amniocentesis during 15-35 weeks of gestation. Exclusion Criteria: * A history of venous thromboembolism * Systemic disease i.e.; diabetes, hypertension, hypo or hyper-thyroidism, * Anticoagulant treatment * Abnormal embryo

Locations (1)

Dept of Obstetrics and Gynecology, Rambam-Health Care Campus

Haifa, Israel

RECRUITING

Central Contacts

Galit Sarig, Ph.D

CONTACT

+972-50-2061462 g_sarig@rambam.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.